Brit Mollenhauer Selected Research

Autoimmune Diseases of the Nervous System

1/2019

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brit Mollenhauer Research Topics

Disease

110	Parkinson Disease (Parkinson's Disease) 05/2024 - 01/2006
43	Dementia (Dementias) 02/2024 - 08/2003
35	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 11/2004
33	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2003
23	Disease Progression 05/2024 - 01/2005
22	Cognitive Dysfunction 02/2024 - 01/2006
9	Synucleinopathies 01/2023 - 03/2011
9	Multiple System Atrophy 10/2022 - 03/2011
8	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022 - 08/2003
7	Parkinsonian Disorders (Parkinsonism) 10/2022 - 10/2010
6	Neuroinflammatory Diseases 02/2023 - 01/2022
6	Movement Disorders (Movement Disorder) 01/2023 - 07/2009
5	Tremor (Tremors) 01/2022 - 12/2011
5	Sporadic Creutzfeldt-Jakob Disease 01/2022 - 10/2008
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2021 - 03/2011
4	Atrophy 03/2024 - 11/2005
4	REM Sleep Behavior Disorder 01/2023 - 07/2017
4	Inflammation (Inflammations) 01/2023 - 08/2017
4	Nervous System Diseases (Neurological Disorders) 01/2019 - 03/2011
4	Frontotemporal Dementia (Semantic Dementia) 10/2015 - 10/2008
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022 - 06/2017
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2013 - 01/2011
2	Anosmia 01/2023 - 07/2022
2	Prodromal Symptoms 01/2023 - 01/2020
2	Cerebellar Ataxia (Dysmetria) 10/2022 - 01/2019
2	Fatal Familial Insomnia 01/2022 - 01/2021
2	Dystonia (Limb Dystonia) 01/2022 - 01/2021
2	Corticobasal Degeneration 12/2021 - 10/2014
2	Hypokinesia (Bradykinesia) 01/2021 - 12/2018
2	Lewy Body Disease (Lewy Body Dementia) 01/2016 - 10/2015
2	Brain Diseases (Brain Disorder) 01/2015 - 03/2011
2	Primary Progressive Aphasia 10/2014 - 01/2011
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2008 - 10/2007
1	Disease Susceptibility (Diathesis) 04/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2023
1	Encephalitis (Encephalitis, Rasmussen) 02/2023
1	Gliosis 01/2023
1	Autonomic Nervous System Diseases (Dysautonomia) 10/2022
1	Striatonigral Degeneration 10/2022
1	Cerebellar Diseases (Cerebellar Syndrome) 10/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2021
1	Dyskinesias (Dyskinesia) 05/2021

Drug/Important Bio-Agent (IBA)

103	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2004
57	SynucleinsIBA 02/2024 - 06/2010
19	Proteins (Proteins, Gene)FDA Link 02/2023 - 01/2006
14	Amyloid (Amyloid Fibrils)IBA 02/2024 - 01/2011
14	alpha-SynucleinIBA 10/2022 - 08/2008
9	tau Proteins (tau Protein)IBA 12/2021 - 01/2005
8	Amyloid beta-PeptidesIBA 01/2016 - 08/2003
6	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2012
6	EnzymesIBA 03/2021 - 01/2006
6	Peptides (Polypeptides)IBA 07/2012 - 08/2003
5	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2024 - 12/2018
4	Dopamine (Intropin)FDA LinkGeneric 03/2024 - 11/2017
4	AutoantibodiesIBA 10/2022 - 10/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 04/2010
3	Levodopa (L Dopa)FDA LinkGeneric 05/2021 - 09/2017
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
3	Leucine (L-Leucine)FDA Link 01/2021 - 01/2020
3	Apolipoproteins E (ApoE)IBA 12/2020 - 04/2014
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 04/2013
3	AntibodiesIBA 01/2020 - 10/2014
3	Fatty Acid Binding Protein 3IBA 07/2017 - 11/2004
3	ApolipoproteinsIBA 01/2016 - 01/2006
3	ImmunosorbentsIBA 09/2015 - 01/2007
2	Amino Acids FDA Link 04/2023 - 01/2022
2	Codon (Codons)IBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 01/2022
2	Prion ProteinsIBA 01/2022 - 01/2021
2	Uric Acid (Urate)IBA 01/2020 - 01/2019
2	Immunoglobulin A (IgA)IBA 01/2019 - 10/2014
2	Immunoglobulin G (IgG)IBA 01/2019 - 10/2014
2	N-Methylaspartate (NMDA)IBA 01/2019 - 10/2014
2	Immunoglobulin M (IgM)IBA 01/2019 - 10/2014
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2015 - 04/2014
2	EpitopesIBA 10/2014 - 11/2012
2	Cholinergic Agents (Cholinergics)IBA 04/2014 - 10/2010
2	Protein Isoforms (Isoforms)IBA 11/2012 - 01/2006
2	14-3-3 Proteins (14-3-3 Protein)IBA 10/2008 - 01/2007
1	Qa-SNARE Proteins (Syntaxin)IBA 05/2024
1	ProteomeIBA 02/2023
1	IronIBA 02/2023
1	fibroblast growth factor 21IBA 01/2023
1	Cystatin BIBA 01/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2023
1	Messenger RNA (mRNA)IBA 11/2022
1	Lipoproteins (Lipoprotein)IBA 02/2022
1	ORALIT (ORS)IBA 01/2022
1	PrionsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Histone-Lysine N-MethyltransferaseIBA 01/2022
1	BenzodiazepinesIBA 05/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Small Untranslated RNAIBA 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021

Therapy/Procedure

9	Therapeutics 03/2024 - 10/2016
1	Precision Medicine 01/2024
1	Deep Brain Stimulation 01/2022
1	Intravenous Infusions 01/2022